EVIDENCE FOR NOVEL BINDING-SITES ON THE PLATELET GLYCOPROTEIN IIB AND IIIA SUBUNITS AND IMMOBILIZED FIBRINOGEN

被引:21
|
作者
PARISE, LV
STEINER, B
NANNIZZI, L
CRISS, AB
PHILLIPS, DR
机构
[1] UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,CARDIOVASC RES INST,SAN FRANCISCO,CA 94141
[2] UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94141
[3] UNIV N CAROLINA,SCH MED,CTR THROMBOSIS & HEMOSTASIS,CHAPEL HILL,NC 27599
基金
美国国家卫生研究院;
关键词
D O I
10.1042/bj2890445
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was designed to examine the interaction of the purified platelet glycoprotein IIb-IIIa complex (GP IIb-IIIa or integrin alpha(IIb)beta3) and the individual subunits of the complex with immobilized fibrinogen. Although I-125-GP IIb-IIIa binding to fibrinogen immobilized on Sepharose was specific, this inter-action exhibited properties distinct from those of reversible fibrinogen binding to platelets: I-125-GP IIb-IIIa binding appeared irreversible, but non-covalent, Ca2+-independent, and was inhibited only weakly, or not at all, by the anti-(GP IIb-IIIa) monoclonal antibodies 10E5 and 7E3 and synthetic peptides from known platelet-binding domains of fibrinogen. Reversibly dissociated GP IIb or GP IIIa subunits inhibited I-125-GP IIb-IIIa binding to immobilized fibrinogen and bound directly to the fibrinogen. However, these subunits did not bind to peptides derived from known platelet-binding domains within the fibrinogen alpha- and gamma-chains, although the GP IIb-IIIa complex did. These results show that the complexed form of full-length GP IIb and GP IIIa is required for binding to these synthetic peptides, but not necessarily for binding to immobilized fibrinogen. Thus GP IIb-IIIa can bind to immobilized fibrinogen by a distinct mechanism that appears to involve novel binding sites on each subunit of the GP IIb-IIIa complex and on fibrinogen.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 50 条
  • [41] Oral platelet glycoprotein IIb/IIIa inhibitors
    Kereiakes, DJ
    CORONARY ARTERY DISEASE, 1999, 10 (08) : 581 - 594
  • [42] Oral platelet glycoprotein IIb/IIIa inhibition
    Newby L.K.
    McGuire D.K.
    Current Cardiology Reports, 2000, 2 (5) : 372 - 377
  • [43] EFFECT OF MODIFICATIONS OF PLATELET GLYCOPROTEIN IIB ON THE EXPRESSION OF THE GLYCOPROTEIN IIB IIIA HETERODIMER
    KOLODZIEJ, M
    VILAIRE, G
    GONDER, D
    PONCZ, M
    BENNETT, JS
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 655 - 655
  • [44] The era of platelet glycoprotein IIb/IIIa inhibition
    Cannon, CP
    CORONARY ARTERY DISEASE, 1999, 10 (08) : 545 - 546
  • [45] Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters
    Klinkhardt, U
    Kirchmaier, CM
    Westrup, D
    Breddin, HK
    Mahnel, R
    Graff, J
    Hild, M
    Harder, S
    THROMBOSIS RESEARCH, 2000, 97 (04) : 201 - 207
  • [46] Oxidative Modification of Fibrinogen Affects Its Binding Activity to Glycoprotein (GP) IIb/IIIa
    Tetik, Sermin
    Kaya, Kurtulus
    Demir, M.
    Eksioglu-Demiralp, Emel
    Yardimci, Turay
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (01) : 51 - 59
  • [47] Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist
    Seiffert, D
    Thomas, BE
    Bradley, JD
    Munzer, DA
    Tchinnes, MA
    Kornhauser, DM
    Cain, VA
    Hua, TA
    Feuerstein, GZ
    Martin, DE
    Stern, AM
    PLATELETS, 2003, 14 (03) : 179 - 187
  • [48] EXPOSURE OF PLATELET FIBRINOGEN-BINDING SITES BY COLLAGEN, ARACHIDONIC-ACID, AND ADP - INHIBITION BY A MONOCLONAL-ANTIBODY TO THE GLYCOPROTEIN IIB-IIIA COMPLEX
    DIMINNO, G
    THIAGARAJAN, P
    PERUSSIA, B
    MARTINEZ, J
    SHAPIRO, S
    TRINCHIERI, G
    MURPHY, S
    BLOOD, 1983, 61 (01) : 140 - 148
  • [49] EFFECTS OF AGE, SEX AND THE ORAL-CONTRACEPTIVE ON THE PLATELET MEMBRANE FIBRINOGEN BINDING-SITE (GLYCOPROTEIN-IIB GLYCOPROTEIN-IIIA)
    CAHILL, M
    MISTRY, R
    CHAPMAN, C
    WOOD, JK
    BARNETT, DB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (01) : 11 - 15
  • [50] EXPRESSION OF THE PLATELET FIBRINOGEN RECEPTOR INVOLVES A CONFORMATIONAL CHANGE IN THE MEMBRANE GLYCOPROTEIN-IIB-GLYCOPROTEIN-IIIA COMPLEX
    SHATTIL, SJ
    HOXIE, JA
    CUNNINGHAM, MC
    BRASS, LF
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 50 - 50